Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancerNamrata S. Patil, David S. Shames, Jason Cheng et al.|Cancer Cell|2022Cited by 403
Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug SelectionAndrew G. Polson, Allen Ebens, Jill Calemine-Fenaux et al.|Cancer Research|2009Cited by 248
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockadeBarzin Y. Nabet, David S. Shames, Habib Hamidi et al.|Cancer Cell|2024Cited by 154
IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour controlBéatrice Bréart, Nathaniel R. West, Katherine Williams et al.|Nature|2025Cited by 45